Solvay Cert Refusal Leaves FCA Circuit Split In Place
The U.S. Supreme Court refused Monday to review the dismissal of a False Claims Act suit from two former Solvay Pharmaceuticals Inc. sales representatives who accused the drugmaker of using an...To view the full article, register now.
Already a subscriber? Click here to view full article